2160 Participants Needed

Education + Patient Navigation for Cancer Screening

(NYC CONNECT Trial)

Recruiting at 2 trial locations
CT
PC
Overseen ByPerla Chebli, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to boost cancer screening rates for breast, cervical, and colorectal cancers. Researchers are testing whether combining community health worker support (Patient Navigation Services) with customized educational materials is more effective than providing education alone. The trial seeks men and women who are due for cancer screenings and speak English, Spanish, Haitian-Creole, French, or Chinese. Participants should live in certain neighborhoods in New York City and have no prior cancer diagnosis.

As an unphased trial, this study offers participants the chance to contribute to innovative strategies that could enhance cancer screening rates in their communities.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on cancer screening and education, so it's unlikely that your medications will be affected, but you should confirm with the trial organizers.

What prior data suggests that these strategies are safe for increasing cancer screening rates?

Research shows that patient navigation programs are generally safe and easy for people to use. These programs involve community health workers who guide patients through the healthcare system, especially for cancer screenings like breast, cervical, and colorectal cancer.

Studies have found that these programs help patients complete their screenings more quickly and effectively. One study showed that patient navigation services assist patients in overcoming obstacles to getting necessary screenings, such as scheduling, insurance, and other non-medical issues.

These programs have been successfully used in different healthcare systems, indicating their safety in similar settings. No reports of safety concerns or negative effects have been directly linked to patient navigation services, making them a dependable option for supporting patients in their healthcare journey.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how patient navigation (PN), both less intensive and more intensive, can enhance cancer screening outcomes. Unlike traditional methods that often rely heavily on patients navigating the healthcare system alone, these PN approaches provide personalized support through community health workers (CHWs). The more intensive PN includes additional guidance on social services and culturally tailored education, which could improve access and adherence to cancer screening, especially in underserved communities. This trial aims to find out whether such comprehensive support can lead to better screening rates and earlier detection, potentially transforming how preventative care is delivered.

What evidence suggests that this trial's treatments could be effective for increasing cancer screening rates?

Research has shown that community health workers can significantly increase breast, cervical, and colorectal cancer screening rates. In this trial, participants in the Patient Navigation (PN) arm will receive navigation for cancer screening from community health workers, a method proven to help patients overcome obstacles and complete screenings on time. Specifically, low-income minority patients experienced a better quality of life with assistance from community health workers. Participants in the Less Intensive (LI) arm will receive culturally relevant educational materials, which also encourage screening. Together, these strategies effectively raise cancer screening rates, making them promising methods for improving early cancer detection.15678

Who Is on the Research Team?

CT

Chau Trinh, PhD

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for English, Spanish, Haitian-Creole, or Chinese Mandarin speakers in specific NYC areas who are due for breast, cervical, or colorectal cancer screenings. Women should be 21-75 years old and men 50-75. Exclusions include those with total colectomy, current cancer navigation program participants, hospice care patients, certain advanced illnesses or long-term institution residents over 66 years old.

Inclusion Criteria

I am a woman aged 50-74 without recent mammogram, Pap smear, HPV test, or colorectal screening.
Lives in East Flatbush (zip codes: 11236, 11203, 11212); Sunset Park (zip codes: 11215, 11220, 11232); Highbridge (zip code 10452); or Morrisania (zip codes: 10456, 10459)
I am a man who is not current with my colorectal cancer screenings.
See 2 more

Exclusion Criteria

I am currently receiving hospice care.
I have had my entire colon removed due to colorectal cancer.
Pregnancy (breast and cervical cancer only)
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive culturally and linguistically tailored cancer education and navigation services for cancer screening

6 months
Surveys at baseline, 3 months, and 6 months

Follow-up

Participants are monitored for cancer screening completion and social service needs

4 weeks

Optional Extension

Participants in the LI arm may opt to receive full navigational support provided to the PN arm

What Are the Treatments Tested in This Trial?

Interventions

  • Educational Materials
  • Patient Navigation (PN) - Less Intensive
  • Patient Navigation (PN) - More Intensive
Trial Overview The study compares two methods to increase cancer screening rates: one uses tailored educational materials plus community health worker-led patient navigation (PN), while the other provides just the educational materials (less intensive). Participants will also receive help for unmet social needs.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Navigation (PN)Experimental Treatment2 Interventions
Group II: Less Intensive (LI)Active Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

Centers for Disease Control and Prevention

Collaborator

Trials
902
Recruited
25,020,000+

Published Research Related to This Trial

A randomized clinical trial involving 1612 patients showed that patient navigation (PN) significantly improved cancer screening rates for breast, cervical, and colorectal cancers, with completion rates of 10.2% in the PN group compared to 6.8% in the control group.
The PN intervention was particularly effective, leading to higher screening completion rates across all cancer types: breast (23.4% vs 16.6%), cervical (14.4% vs 8.6%), and colorectal (13.7% vs 7.0%), indicating that integrating PN into healthcare can enhance cancer screening in underserved populations.
Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.Percac-Lima, S., Ashburner, JM., Zai, AH., et al.[2022]
A standardized national training program for patient navigators (PNs) was successfully implemented, attended by 116 PNs from 85 cities, aimed at reducing cancer health disparities for medically underserved populations.
The training showed significant efficacy, with overall improvements in posttest scores compared to pretest scores, particularly among participants with higher education levels or more work experience.
A national patient navigator training program.Calhoun, EA., Whitley, EM., Esparza, A., et al.[2021]
The Patient Satisfaction with Interpersonal Relationship with Navigator (PSN-I) measure was validated in a study involving 783 participants, demonstrating high internal consistency and reliability (α ranging from 0.95 to 0.96).
The PSN-I effectively captures patient satisfaction with navigators, showing strong correlations with existing satisfaction measures, which suggests it is a reliable tool for assessing the quality of support provided to underserved cancer patients.
Psychometric development and reliability analysis of a patient satisfaction with interpersonal relationship with navigator measure: a multi-site patient navigation research program study.Jean-Pierre, P., Fiscella, K., Winters, PC., et al.[2022]

Citations

Use of Community Health Workers and Patient Navigators ...Our findings support the effectiveness of CHW/PN programs to improve completion and timeliness of breast, cervical, and colorectal cancer screening in FQHCs.
Community Health Worker Navigation for Patients With ...Low-income minority patients with cancer randomly assigned to a community health worker intervention had significantly improved health related quality of life ...
Effectiveness of Patient Navigation to Increase Cancer ...The goal of this study is to evaluate the effectiveness of patient navigation services in increasing colorectal, breast, and cervical cancer screening rates in ...
Breast Cancer Screening: Patient NavigationPatient navigation services provided through healthcare systems help patients overcome barriers to accessing breast cancer screening.
Patient Navigation Services for Breast and Cervical Cancer ...Screening rates are lower for women seen in Federally Qualified Health Centers (FQHC) compared with the general U.S. population based on data ...
Executive Summary - Enhancing Patient Navigation with ...Patient navigation has been proven to reduce cancer disparities—a critical problem facing the National Cancer Program—by addressing individual ...
Colorectal Cancer Screening: Patient NavigationPatient navigation services provided through healthcare systems help patients overcome barriers to accessing colorectal cancer screening.
Patient navigation across the cancer care continuum: An ...Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security